Saudi Arabia q-PCR Reagents Market - Industry Trends and Forecast to 2030

List of Tables

The Saudi Arabia q-PCR Reagents Market is expected to reach USD 41,798.44 thousand by 2030, from USD 22,521.24 thousand in 2022 growing at the CAGR of 8.3 % in the forecast period of 2023 to 2030.

Market Segmentation

Saudi Arabia q-PCR Reagents Market, By Type (Reagents and Consumables), Application (Clinical, Research, Food Product Safety Testing, Forensics, and Others), End User (Hospitals, Diagnostic Centers, Pharmaceutical and Biopharmaceutical Companies, Research and Academic Institute, Clinical Research Organization, Veterinary Labs, Forensic Laboratories, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others) - Industry Trends and Forecast to 2030.

Overview of Saudi Arabia q-PCR Reagents Market Dynamics

Driver
Increasing prevalence of chronic and communicable diseases
Restraint
Stringent rules and regulations
Opportunity
Rise in government funding for healthcare

Market Players

Some of the key players operating in the Saudi Arabia q-PCR reagents market are:

F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Quantabio
Sino Biological Inc.
QIAGEN
TAKARA HOLDINGS INC
Enzo Biochem Inc.
meridian BIOSCIENCE
Tonbo Biosciences (A subsidiary of Cytek Biosciences)
Norgen Biotek Corp.

1 INTRODUCTION 12

1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 OVERVIEW OF SAUDI ARABIA Q-PCR REAGENTS MARKET 12
1.4 LIMITATIONS 14
1.5 MARKETS COVERED 14

2 MARKET SEGMENTATION 17

2.1 MARKETS COVERED 17
2.2 GEOGRAPHICAL SCOPE 18
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 CURRENCY AND PRICING 18
2.5 DBMR TRIPOD DATA VALIDATION MODEL 19
2.6 MULTIVARIATE MODELLING 22
2.7 PRODUCTS LIFELINE CURVE 22
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23
2.9 DBMR MARKET POSITION GRID 24
2.10 MARKET END USER COVERAGE GRID 25
2.11 SECONDARY SOURCES 26
2.12 ASSUMPTIONS 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHT 30

4.1 PESTEL ANALYSIS 31
4.2 PORTER'S FIVE FORCES 32
4.3 GLOBAL QPCR REAGENTS MARKET, PRICING ANALYSIS 33

5 COST ANALYSIS BREAKDOWN 35

6 HEALTHCARE ECONOMY 36

7 INDUSTRY INSIGHTS 37

8 INNOVATION TRACKER AND STRATEGIC ANALYSIS 39

9 TECHNOLOGY ROADMAP 40

10 VALUE CHAIN ANALYSIS 41

11 REGULATIONS 42

12 MARKET OVERVIEW 44

12.1 DRIVERS 46
- 12.1.1 INCREASING PREVALENCE OF CHRONIC AND COMMUNICABLE DISEASES 46
- 12.1.2 INCREASE IN GERIATRIC POPULATION 46
- 12.1.3 INCREASE IN EARLY DIAGNOSIS RATE 46
- 12.1.4 INCREASE IN ADVANCED TECHNOLOGY 47
12.2 RESTRAINTS 48
- 12.2.1 STRINGENT RULES AND REGULATIONS 48
- 12.2.2 HIGH COST OF PRODUCT 48
12.3 OPPORTUNITIES 49
- 12.3.1 RISE IN GOVERNMENT FUNDING FOR HEALTHCARE 49
- 12.3.2 RISE IN HEALTHCARE EXPENDITURE 49
12.4 CHALLENGES 50
- 12.4.1 LACK OF SKILLED WORKFORCE 50
- 12.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS 50

13 SAUDI ARABIA QPCR REAGENTS MARKET, BY TYPE 51

13.1 OVERVIEW 52
13.2 REAGENTS 53
- 13.2.1 MASTER MIX 54
  - 13.2.1.1 DNA 54
  - 13.2.1.2 RNA 54
- 13.2.2 PRIMERS AND DNTPS 54
- 13.2.3 ASSAY 54
- 13.2.4 NUCLEIC ACID GEL STAIN 54
- 13.2.5 DNASE BUFFER 54
- 13.2.6 OTHERS 54
13.2. CONSUMABLES 55
- 13.2.1. PIPETTE TIPS 55
- 13.2.2. TUBES 55
- 13.2.3. PLATES 56
  - 13.2.3.1. STANDARD 56
  - 13.2.3.2. CUSTOM 56
- 13.2.4. SEALING FOILS 56
- 13.2.5. TUBE STRIPS 56
- 13.2.6. OTHERS 56

14. SAUDI ARABIA QPCR REAGENTS MARKET, BY APPLICATION 57

14.2. OVERVIEW 58
14.3. CLINICAL 59
13.3 HUMAN DIAGNOSTICS 60
13.4 VETERINARY DIAGNOSTICS 61
14.4. RESEARCH 62
- 14.4.1. GENE EXPRESSION ANALYSIS 62
  - 14.4.1.1. RESEARCH & ACADEMIC INSTITUTES 63
  - 14.4.1.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 63
  - 14.4.1.3. OTHERS 63
- 14.4.2. GENOTYPING 63
  - 14.4.2.1. RESEARCH & ACADEMIC INSTITUTES 63
  - 14.4.2.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 63
  - 14.4.2.3. OTHERS 63
- 14.4.3. MICROBE AND PATHOGEN DETECTION 64
  - 14.4.3.1. RESEARCH & ACADEMIC INSTITUTES 64
  - 14.4.3.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 64
  - 14.4.3.3. OTHERS 64
- 14.4.4. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) DETECTION 65
  - 14.4.4.1. RESEARCH & ACADEMIC INSTITUTES 65
  - 14.4.4.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 65
  - 14.4.4.3. OTHERS 65
- 14.4.5. DRUG DEVELOPMENT 66
  - 14.4.5.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 66
  - 14.4.5.2. CLINICAL RESEARCH ORGANIZATION 66
  - 14.4.5.3. RESEARCH & ACADEMIC INSTITUTES 66
  - 14.4.5.4. OTHERS 66
- 14.4.6. DRUG DISCOVERY 67
  - 14.4.6.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 67
  - 14.4.6.2. CLINICAL RESEARCH ORGANIZATION 67
  - 14.4.6.3. RESEARCH & ACADEMIC INSTITUTES 67
  - 14.4.6.4. OTHERS 67
- 14.4.7. OTHERS 67
14.5. FOOD PRODUCT SAFETY TESTING 68
- 14.5.1. FOOD REGULATORY AGENCIES 68
- 14.5.2. FOOD TESTING LABORATORIES 68
- 14.5.3. FOOD COMPANIES 68
- 14.5.4. OTHERS 68
14.6. FORENSICS 69
- 14.6.1. PRIVATE FORENSIC LABORATORIES 69
- 14.6.2. PUBLIC FORENSIC LABORATORIES 69
14.7. OTHERS 69

15. SAUDI ARABIA QPCR REAGENTS MARKET, BY END USER 70

15.2. OVERVIEW 71
15.3. HOSPITALS 72
15.4. DIAGNOSTIC CENTERS 72
15.5. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 72
15.6. RESEARCH & ACADEMIC INSTITUTE 72
15.7. CLINICAL RESEARCH ORGANIZATION 72
15.8. VETERINARY LABS 73
15.9. FORENSIC LABORATORIES 73
15.10. OTHERS 73

16. SAUDI ARABIA QPCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL 74

16.2. OVERVIEW 75
16.3. DIRECT TENDER 76
16.4. RETAIL SALES 76
16.5. OTHERS 76

17. SAUDI ARABIA QPCR REAGENTS MARKET: COMPANY LANDSCAPE 77

17.2. COMPANY SHARE ANALYSIS: SAUDI ARABIA 77

18. SWOT ANALYSIS 78

19. COMPANY PROFILE 79

19.2. F. HOFFMANN-LA ROCHE LTD 79
- 19.2.1. COMPANY SNAPSHOT 79
- 19.2.2. REVENUE ANALYSIS 79
- 19.2.3. PRODUCT PORTFOLIO 80
- 19.2.4. RECENT DEVELOPMENT 80
19.3. THERMO FISHER SCIENTIFIC INC. 81
- 19.3.1. COMPANY SNAPSHOT 81
- 19.3.2. REVENUE ANALYSIS 81
- 19.3.3. PRODUCT PORTFOLIO 82
- 19.3.4. RECENT DEVELOPMENTS 82
19.4. AGILENT TECHNOLOGIES, INC. 83
- 19.4.1. COMPANY SNAPSHOT 83
- 19.4.2. REVENUE ANALYSIS 83
- 19.4.3. PRODUCT PORTFOLIO 84
- 19.4.4. RECENT DEVELOPMENTS 84
  - 19.4.4.1. DISTRIBUTION AGREEMENT 84
  - 19.4.4.2. PRODUCT LAUNCH 84
19.5. BIO-RAD LABORATORIES, INC. 85
- 19.5.1. COMPANY SNAPSHOT 85
- 19.5.2. REVENUE ANALYSIS 85
- 19.5.3. PRODUCT PORTFOLIO 86
- 19.5.4. RECENT DEVELOPMENTS 86
19.6. QUANTABIO 87
- 19.6.1. COMPANY SNAPSHOT 87
- 19.6.2. PRODUCT PORTFOLIO 87
- 19.6.3. RECENT DEVELOPMENT 87
19.7. ENZO BIOCHEM INC 88
- 19.7.1. COMPANY SNAPSHOT 88
- 19.7.2. REVENUE ANALYSIS 88
- 19.7.3. PRODUCT PORTFOLIO 89
- 19.7.4. RECENT DEVELOPMENT 89
19.8. MERIDIAN BIOSCIENCE 90
- 19.8.1. COMPANY SNAPSHOT 90
- 19.8.2. PRODUCT PORTFOLIO 90
- 19.8.3. RECENT DEVELOPMENTS 90
19.9. NORGEN BIOTEK CORP 91
- 19.9.1. COMPANY SNAPSHOT 91
- 19.9.2. PRODUCT PORTFOLIO 91
- 19.9.3. RECENT DEVELOPMENT 91
19.10. QIAGEN 92
- 19.10.1. COMPANY SNAPSHOT 92
- 19.10.2. REVENUE ANALYSIS 92
- 19.10.3. PRODUCT PORTFOLIO 93
- 19.10.4. RECENT DEVELOPMENTS 93
19.11. SINO BIOLOGICAL INC. 94
- 19.11.1. COMPANY SNAPSHOT 94
- 19.11.2. PRODUCT PORTFOLIO 94
- 19.11.3. RECENT DEVELOPMENT 94
19.12. TAKARA HOLDINGS INC 95
- 19.12.1. COMPANY SNAPSHOT 95
- 19.12.2. REVENUE ANALYSIS 95
- 19.12.3. PRODUCT PORTFOLIO 96
- 19.12.4. RECENT DEVELOPMENTS 96
19.13. TONBO BIOSCIENCES (A SUBSIDIARY OF CYTEK BIOSCIENCES) 97
- 19.13.1. COMPANY SNAPSHOT 97
- 19.13.2. PRODUCT PORTFOLIO 97
- 19.13.3. RECENT DEVELOPMENT 97

20. QUESTIONNAIRE 98

21. RELATED REPORTS 100

LIST OF TABLES

TABLE 1 THE FOLLOWING ARE THE PRICES OF PRODUCTS (CONSUMABLES AND REAGENTS) OFFERED BY THE COMPANIES 33
TABLE 2 MEDICAL DEVICE CLASSIFICATION SYSTEM: 42
TABLE 3 APPROVAL PROCESS OF MEDICAL DEVICES: 42
TABLE 4 SAUDI ARABIA QPCR REAGENTS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 53
TABLE 5 SAUDI ARABIA REAGENTS IN QPCR REAGENTS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 53
TABLE 6 SAUDI ARABIA MASTER MIX IN QPCR REAGENTS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 54
TABLE 7 SAUDI ARABIA CONSUMABLES IN QPCR REAGENTS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 55
TABLE 8 SAUDI ARABIA PLATES IN QPCR REAGENTS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 56
TABLE 9 SAUDI ARABIA QPCR REAGENTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 59
TABLE 10 SAUDI ARABIA CLINICAL IN QPCR REAGENTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 59
TABLE 11 SAUDI ARABIA HUMAN DIAGNOSTICS IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 60
TABLE 12 SAUDI ARABIA VETERINARY DIAGNOSTICS IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 61
TABLE 13 SAUDI ARABIA RESEARCH IN QPCR REAGENTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 62
TABLE 14 SAUDI ARABIA GENE EXPRESSION ANALYSIS IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 62
TABLE 15 SAUDI ARABIA GENOTYPING IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 63
TABLE 16 SAUDI ARABIA MICROBE AND PATHOGEN DETECTION IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 64
TABLE 17 SAUDI ARABIA SINGLE NUCLEOTIDE POLYMORPHISM (SNP) DETECTION IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 65
TABLE 18 SAUDI ARABIA DRUG DEVELOPMENT IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 66
TABLE 19 SAUDI ARABIA DRUG DISCOVERY IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 67
TABLE 20 SAUDI ARABIA FOOD PRODUCT SAFETY TESTING IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 68
TABLE 21 SAUDI ARABIA FORENSIC IN QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 69
TABLE 22 SAUDI ARABIA QPCR REAGENTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 72
TABLE 23 SAUDI ARABIA QPCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 76

LIST OF FIGURES

FIGURE 1 SAUDI ARABIA Q-PCR REAGENTS MARKET: SEGMENTATION 17
FIGURE 2 SAUDI ARABIA Q-PCR REAGENTS MARKET: DATA TRIANGULATION 19
FIGURE 3 SAUDI ARABIA Q-PCR REAGENTS MARKET: DROC ANALYSIS 20
FIGURE 4 SAUDI ARABIA Q-PCR REAGENTS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 21
FIGURE 5 SAUDI ARABIA Q-PCR REAGENTS MARKET: COMPANY RESEARCH ANALYSIS 21
FIGURE 6 SAUDI ARABIA Q-PCR REAGENTS MARKET: INTERVIEW DEMOGRAPHICS 23
FIGURE 7 SAUDI ARABIA Q-PCR REAGENTS MARKET: DBMR MARKET POSITION GRID 24
FIGURE 8 SAUDI ARABIA Q-PCR REAGENTS MARKET: MARKET END USER GRID 25
FIGURE 9 SAUDI ARABIA Q-PCR REAGENTS MARKET: SEGMENTATION 29
FIGURE 10 INCREASING GERIATRIC POPULATION AND INCREASE IN EARLY DIAGNOSIS RATE IS EXPECTED TO DRIVE THE GROWTH OF THE SAUDI ARABIA Q-PCR REAGENTS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030 30
FIGURE 11 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE SAUDI ARABIA Q-PCR REAGENTS MARKET FROM 2023 TO 2030 30
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF SAUDI ARABIA Q-PCR REGANETS MARKET 45
FIGURE 13 SAUDI ARABIA QPCR REAGENTS MARKET: BY TYPE, 2022 52
FIGURE 14 SAUDI ARABIA QPCR REAGENTS MARKET: BY APPLICATION, 2022 58
FIGURE 15 SAUDI ARABIA QPCR REAGENTS MARKET: BY END USER, 2022 71
FIGURE 16 SAUDI ARABIA QPCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, 2022 75
FIGURE 17 SAUDI ARABIA Q-PCR REAGENTS MARKET: COMPANY SHARE 2022 (%) 77